Investigation of Aframomum melegueta compounds as ERK5 inhibitor related to breast cancer via molecular docking and dynamic simulation
2025In Silico PharmacologyJournalOpen access
10.1007/s40203-025-00304-wFull text6 citations
2025In Silico PharmacologyJournalOpen access
10.1007/s40203-025-00304-wFull text6 citations
11 authors across 5 institutions in 2 countries.
Assignment is probabilistic — a work belongs to several fields in proportions.
Several sources describing one work is the point — it means the record rests on more than one authority.
2025 · In Silico Pharmacology · 6 citations
https://openalex.org/W4406824181